Literature DB >> 8968557

Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits.

C Greenlees1, C L Wainwright, R M Wadsworth.   

Abstract

1. A comparison of the effects of dietary and genetically-induced hypercholesterolaemia on the vasodilator and antiaggregatory capacity of the endothelium was made in rabbit isolated subclavian artery rings. 2. Dietary-induced hypercholesterolaemia in NZW rabbits decreased the maximum relaxation to carbachol (0.01-10 microM) and calcimycin (0.01-0.1 microM) in vessel rings precontracted with 5-hydroxytryptamine (5-HT), 0.1 microM), when compared to responses observed in rings obtained from control normocholesterolaemic NZW rabbits. The relaxant responses to SIN-1 (3-(4-morpholinyl)-sydnonimine hydrochloride) were attenuated but were not significantly different from controls. In Froxfield genetically hypercholesterolaemic (FHH) rabbits, the maximum relaxations to carbachol, calcimycin and SIN-1 were all reduced significantly. 3. Neither genetic nor dietary-induced hypercholesterolaemia modified the contractile responses of vessel rings to either KCl (10-100 mM) or 5-HT (0.01-10 microM). 4. Endothelium-dependent inhibition of collagen-induced platelet aggregation in whole blood was demonstrated by stimulation of a vessel ring, incorporated into the blood sample, with carbachol (10 microM, final blood concentration). This effect was inhibited by NG-nitro-L-arginine (L-NOARG, 100 microM). SIN-1 (10 microM, final blood concentration) also decreased whole blood platelet aggregation, but only in the presence of an unstimulated vessel ring, and this was unaffected by L-NOARG. Superoxide dismutase (150 u ml-1) did not influence the inhibition of aggregation by either a carbachol-stimulated vessel ring or by SIN-1. 5. Carbachol-stimulated artery rings from FHH rabbits inhibited platelet aggregation to a similar extent to that seen with rings from control normocholesterolaemic rabbits. Rings from hypercholesterolaemic NZW rabbits, however, did not significantly inhibit platelet aggregation when stimulated with carbachol. SIN-1 inhibited platelet aggregation in the presence of rings from either group of hypercholesterolaemic rabbits. 6. Hypercholesterolaemia induced by dietary modification induces changes in endothelial function which are characteristically different from those seen in genetically hypercholesterolaemic rabbits. It appears that dietary-induced hypercholesterolaemia primarily decreases NO release from the endothelium, while in genetically-induced hypercholesterolaemic vessel rings NO is released but there is a decreased responsiveness of the vascular smooth muscle cells to NO. This may reflect differences in the age and severity of the atherosclerotic lesions in the two groups of rabbits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968557      PMCID: PMC1915835          DOI: 10.1111/j.1476-5381.1996.tb16060.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries.

Authors:  R A Cohen; K M Zitnay; C C Haudenschild; L D Cunningham
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

Review 2.  Platelet activation by plasma lipoproteins.

Authors:  M Aviram; J G Brook
Journal:  Prog Cardiovasc Dis       Date:  1987 Jul-Aug       Impact factor: 8.194

Review 3.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

4.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.

Authors:  J M Sneddon; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

6.  Platelet activation by IgE and aspirin.

Authors:  M Joseph; A Capron; A Tsicopoulos; J C Ameisen; J B Martinot; A B Tonnel
Journal:  Agents Actions Suppl       Date:  1987

7.  Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo.

Authors:  R Bhardwaj; C P Page; G R May; P K Moore
Journal:  Eur J Pharmacol       Date:  1988-11-15       Impact factor: 4.432

8.  Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit.

Authors:  L Jayakody; M Senaratne; A Thomson; T Kappagoda
Journal:  Circ Res       Date:  1987-02       Impact factor: 17.367

9.  Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits.

Authors:  J A Osborne; M J Siegman; A W Sedar; S U Mooers; A M Lefer
Journal:  Am J Physiol       Date:  1989-03

10.  Characterization of the morphological and functional alterations in rabbit subclavian artery subjected to balloon angioplasty.

Authors:  P Hadoke; C L Wainwright; R M Wadsworth; K Butler; M J Giddings
Journal:  Coron Artery Dis       Date:  1995-05       Impact factor: 1.439

View more
  3 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

2.  The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart disease.

Authors:  Jonathan Watt; Marie-Ann Ewart; Fiona H Greig; Keith G Oldroyd; Roger M Wadsworth; Simon Kennedy
Journal:  Thromb Res       Date:  2012-04-19       Impact factor: 3.944

3.  Can we extrapolate the outcomes of in vitro studies on murine endothelium to studies of human platelet-endothelium interactions? A technical note.

Authors:  Jacek Golański; Marta Michalska; Joanna Polowinczak-Przybyłek; Urszula Krajewska; Cezary Watała
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.